Download PDF
Thromb Haemost 2025; 125(01): 001-002
DOI: 10.1055/a-2495-2105
Editorial

Welcoming 2025—A Year of Collaboration and Progress

Gregory Y. H. Lip 
1   Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom
2   Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
,
Anne Rigby
3   Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany
,
Christian Weber
3   Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany
4   German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
5   Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

As we begin 2025, it is a time to reflect on our journey and the exciting initiatives that continue to shape the future of Thrombosis & Haemostasis. This editorial offers a moment to celebrate recent achievements and introduce the new strategies, collaborations, and opportunities we look forward to in the year ahead.

* These authors serve as co-corresponding authors.




Publication History

Article published online:
03 January 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Potpara T, Romiti GF, Sohns C. The 2024 European Society of Cardiology Guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician's perspective. Thromb Haemost 2024; 124 (12) 1087-1094
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Bejjani A, Bikdeli B. Direct oral anticoagulants: quick primer on when to use and when to avoid. Thromb Haemost 2024; (e-pub ahead of print).
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Wang Y, Guo Y, Qin M. et al; Expert Reviewers. 2024 Chinese Expert Consensus Guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): executive summary. Thromb Haemost 2024; 124 (10) 897-911
    Thieme ConnectPubMedSearch in Google Scholar
  • 4 Mackay GA, Gall C, Jampana R, Sleith C, Lip GYH. SIGN Dementia Guideline Development Group. Scottish Intercollegiate Guidelines Network guidance on dementia: the investigation of suspected dementia (SIGN 168) with focus on biomarkers—executive summary. Thromb Haemost 2024; (e-pub ahead of print).
    Thieme ConnectPubMedSearch in Google Scholar
  • 5 Ortega-Martorell S, Olier I, Ohlsson M, Lip GYH. TARGET Consortium. TARGET: a major European project aiming to advance the personalised management of atrial fibrillation-related stroke via the development of health virtual twins technology and artificial intelligence. Thromb Haemost 2024; (e-pub ahead of print).
    Thieme ConnectPubMedSearch in Google Scholar
  • 6 Hristov M, Weber C. Monocyte subsets in cardiovascular disease: a biomarker perspective. Thromb Haemost 2024; (e-pub ahead of print).
    Thieme ConnectPubMedSearch in Google Scholar
  • 7 Weber C, Rigby A, Lip GYH. Thrombosis and Haemostasis 2024 Editors' Choice Papers. Thromb Haemost 2025; 125 (01) 85-91
    PubMedSearch in Google Scholar
  • 8 Rigby A, Albisetti M, Favaloro EJ. et al. Reflections on World Thrombosis Day 2024. Thromb Haemost 2024; (e-pub ahead of print).
    Thieme ConnectPubMedSearch in Google Scholar